课题基金 / 基金详情

INDUCTION OF TOLERANCE VIA DEC-205 ON DENDRITIC CELLS

INDUCTION OF TOLERANCE VIA DEC-205 ON DENDRITIC CELLS
通过 DEC-205 对树突状细胞诱导耐受
批准号:
6268244
负责人:
Ralph Marvin Steinman
金额:
$8.22万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-06-01 至 1999-05-31

项目摘要

项目成果

Ralph Marvin Steinman的其他基金

相似基金

相关文献

中文摘要
翻译
树突状细胞是专门的抗原呈递细胞[APC], 原位启动T细胞依赖性免疫。 树突状细胞也可以 介导的耐受性,集中在胸腺和外周, 好. 该子项目将探讨树突状细胞的潜力, 沉默T细胞。 我们将利用受体DEC-205, 在树突状细胞和某些上皮细胞上丰富。 DEC-205被分离 并进行克隆,其具有DECalectin的结构。 DEC-205介导 兔抗DEC-205通过包被小凹的吸附摄取, 多泡内体,并有效地呈递给Ig特异性,T 细胞 当将针对DEC-205的大鼠mAb注射到小鼠中时,mAb靶向 但在一周内,T细胞变得耐受树突细胞, CFA中大鼠IG免疫原性攻击。 在这里,我们将通过DEC-205在体内靶向肽,以确定组织 注射肽的分布及其耐受活性。 我们 假设胸腺耐受性将继之而来, 髓质树突状细胞和可能的皮质上皮细胞,而 由于靶向未成熟亚群, 或者用高剂量的 肽。 对大鼠抗DEC-1的耐受性的剂量要求和持续时间 205将与靶向其他细胞和树突状细胞的大鼠mAb进行比较。 细胞成分 一种与I-A/B结合并被识别的I-Ea肽 将Y-Ae mAb偶联至抗DEC-205,并用于可视化 体内加工和靶向,以及对I-Ea肽的耐受性。 同样地,流感HA肽将偶联至抗DEC-205,以遵循 HA特异性TCR中中枢和外周T细胞应答 转基因株系 与此同时,我们将筛选一大组糖蛋白, 非糖基化蛋白质通过DEC-205呈递, DEC-205结构域的结构-功能分析, 演示文稿. 初步数据显示,截至DEC-205, 转染子 将评估体内糖蛋白耐受性。 最后 DEC-205基因缺失在骨髓和非骨髓中的作用 将记录衍生的APC隔室。 因此,在本计划的范围内,我们将确定积极的 DEC-205的配体,并测试是否通过此靶向MHC II产物 受体为自身免疫干预提供了新的分子途径。 通过将自身抗原靶向APC的关键亚群,这种方法旨在 沉默I型糖尿病和其他疾病中的致病T细胞 自身免疫性疾病
英文摘要
Dendritic cells are specialized antigen presenting cells [APCs] for initiating T cell-dependent immunity in situ. Dendritic cells also can mediate tolerance, centrally in the thymus and perhaps peripherally as well. This subproject will approach the potential of dendritic cells to silence T cells. We will take advantage of a receptor, DEC-205, that is abundant on Dendritic and certain Epithelial Cells. DEC-205 was isolated and cloned, and has the structure of a DECalectin. DEC-205 mediates adsorptive uptake of rabbit anti-DEC-205 via coated pits and multivesicular endosomes, and efficient presentation to Ig-specific, T cells. When a rat mAb to DEC-205 is injected into mice, the mAb targets to dendritic cells but within a week, the T cells become tolerant to an immunogenic challenge of rat Ig in CFA. Here we will target peptides via DEC-205 in vivo to determine the tissue distribution of the injected peptide and its tolerizing activity. We hypothesize that thymic tolerance would ensue following presentation by medullary dendritic cells and possibly cortical epithelium, while peripheral tolerance may develop because of targeting to immature subsets of dendritic cells or by charging these APCs with very high doses of peptide. The dose requirements and duration of tolerance to rat anti-DEC- 205 will be compared with rat mAbs targeted to other cells and dendritic cell constituents. An I-Ea peptide that binds to I-A/b and is recognized by the Y-Ae mAb will be coupled to anti-DEC-205 and used to visualize processing and targeting in vivo, as well as tolerance to I-Ea peptide. Likewise an influenza HA peptide will be coupled to anti-DEC-205 to follow the response of central and peripheral T cells in HA-specific TCR transgenic lines. In parallel, we will screen a large panel of glycoproteins and nonglycosylated proteins for presentation via DEC-205 and carry out structure-function analyses of the DEC-205 domains that are involved in presentation. Preliminary data show presentation of fetuin by DEC-205 transfectants. Glycoprotein tolerance in vivo will be assessed. Finally the effects of the genetic deletion of DEC-205 in marrow and nonmarrow derived APC compartments will be documented. Within the context of this program, we will therefore identify active ligands for DEC-205 and test if targeting MHC II products via this receptor provides a new molecular approach for autoimmune intervention. By targeting autoantigens to critical subsets of APCs, this approach aims to silence disease-producing T cells in type I diabetes and other autoimmune diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DETECTION OF MHC CLASS II PEPTIDES
  • 批准号:
    8361586
  • 项目类别:
  • 资助金额:
    $2.18万
  • 财政年份:
    2011
  • 负责人:
    Ralph Marvin Steinman
  • 依托单位:
DC-targeted DNA vaccines
  • 批准号:
    7774820
  • 项目类别:
  • 资助金额:
    $43.51万
  • 财政年份:
    2009
  • 负责人:
    Ralph Marvin Steinman
  • 依托单位:
FACS
  • 批准号:
    7645166
  • 项目类别:
  • 资助金额:
    $19.8万
  • 财政年份:
    2008
  • 负责人:
    Ralph Marvin Steinman
  • 依托单位:
Dendritic cells induce tolerance to pancreatic islets
  • 批准号:
    7645165
  • 项目类别:
  • 资助金额:
    $34.25万
  • 财政年份:
    2008
  • 负责人:
    Ralph Marvin Steinman
  • 依托单位:
海外基金